Suchen und finden Sie den CMO / CDMO, den Sie brauchen
Discover highly skilled partners for your drug development and manufacturing project.
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Eine von der USFDA zugelassene API- und Intermediate-Produktionsanlage.
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Chemisch-pharmazeutische Anlage
Location available after registration
These facilities match your main criteria but not all optional filters.
Avara Pharmaceutical Services | Arecibo Site
AVARA
Kommerzielle Produktionsanlage für orale feste Dosierungen (OSD) mit ausgeprägter Expertise im Bereich kontrollierter Substanzen (DEA II V).
BATCH-GRÖSSE: Mittel, Groß
THERAPEUTISCHE FACHGEBIETE (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (N) Nervous system, (B) Blood and blood forming organs
KATEGORIE/PRODUKT: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
COMPLIANCE: Roszdravnadzor (Russia GMP), EMA (EU-GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), FDA (cGMP), Gesundheit Kanada (Kanada GMP), MFDS/KFDA (Republik Korea GMP), ICH
KONTROLLIERTE SUBSTANZEN: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
MÄRKTE: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), Health Canada (Canada)
VERWENDUNG: Menschlich
DIENSTLEISTUNGEN: Analytical / QC services, Manufacturing services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/Tag)
REGION: North America
Avara Pharmaceutical Services | Norman Site
AVARA
Auftragsfertigungsanlage, spezialisiert auf orale feste Dosierung (OSD) für die klinische und kommerzielle Versorgung.
BATCH-GRÖSSE: Klein, Mittel, Groß
THERAPEUTISCHE FACHGEBIETE (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (N) Nervous system, (B) Blood and blood forming organs
KATEGORIE/PRODUKT: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
COMPLIANCE: Roszdravnadzor (Russia GMP), EMA (EU-GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MHRA (UK GMP), TGA (Australia GMP), FDA (cGMP), Gesundheit Kanada (Kanada GMP), MFDS/KFDA (Republik Korea GMP), ICH
KONTROLLIERTE SUBSTANZEN: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
MÄRKTE: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), Health Canada (Canada), MHRA (UK)
VERWENDUNG: Menschlich
DIENSTLEISTUNGEN: Analytical / QC services, Manufacturing services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/Tag)
REGION: North America
TRADICHEM INDUSTRIAL SERVICES
TRADICHEM INDUSTRIAL SERVICES S.L.
HIPERING® TECHNOLOGY – DAS TOR FÜR LEAN MANUFACTURING
BATCH-GRÖSSE: Klein, Mittel, Groß
COMPLIANCE: EMA (EU-GMP), Weltgesundheitsorganisation (GMP / HACCP), FDA (cGMP), ISO
KATEGORIE/PRODUKT: SERVICES, PARTICLE ENGINEERING, NUTRAZEUTIKA
REGION: Europe
VERWENDUNG: Menschlich, Veterinär
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/Tag)
DIENSTLEISTUNGEN: Manufacturing services, Development services
MÄRKTE: FDA (USA), EMA (EU)
BSL (Biologische Sicherheitsstufe): 1, 2
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Trockenpulver-Inhalationsanlage.
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
F&E und analytische Dienstleistungen, Technologietransfer und Einführung neuer Produkte sowie Herstellung fester und flüssiger oraler Darreichungsformen.
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Ihr vertrauenswürdiger GMP-CDMO für fortschrittliche aseptische und nicht-aseptische Herstellung pharmazeutischer Arzneimittel, Formulierungsentwicklung und ana
Location available after registration